| Epithelial Neoplasm studied in …STUDIED_INderived200 of 8,639show all (up to 200) |
|---|
| → studied in | NCT00027326enrolling by invitation Collection of Blood and Urine From Patients Undergoing Radiation Therapy · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423306Phase 2 · completed A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02345265Phase 2 · active not recruiting Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Fallopian Tube Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02502266Phase 2/Phase 3 · active not recruiting Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Fallopian Tube Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03793179Phase 3 · active not recruiting Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Invasive Bladder Plasmacytoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03897543Phase 1/Phase 2 · completed ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04085900recruiting Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04175912Phase 2 · active not recruiting Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04181060Phase 3 · recruiting Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04267848Phase 3 · recruiting Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04310007Phase 2 · active not recruiting Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04548752Phase 2 · active not recruiting Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04605913Phase 1/Phase 2 · active not recruiting Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05081193Phase 2 · active not recruiting Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176223Phase 2 · completed 68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05273554Phase 1 · completed A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05322590Phase 1/Phase 2 · active not recruiting BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05642195Phase 1/Phase 2 · suspended Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05803382Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05874921recruiting uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05877599Phase 1 · recruiting A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06406465Phase 2 · recruiting A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06524544Phase 3 · recruiting A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06589804Phase 3 · recruiting Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06605664Phase 2 · recruiting Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06738303Phase 2 · recruiting Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061977Phase 3 · recruiting Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Cervical Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07574541Phase 2 · not yet recruiting Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07607769recruiting MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment. · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07671092early Phase 1 · recruiting Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705035Phase 1 · recruiting DBC-664 in Adult Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07845617recruiting Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07847671Phase 2 · not yet recruiting Fecal Microbiota Transplantation With QL1706 Plus Bevacizumab for Advanced HCC · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07848243Phase 2 · recruiting Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Cervical Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03976323Phase 3 · completed Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006) · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04071223Phase 2 · active not recruiting Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Unclassified Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644770Phase 1 · active not recruiting A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04645160Phase 1/Phase 2 · recruiting Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05112601Phase 2 · recruiting Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05540925completed Vascular Invasion Prediction Via a Multimodal Model Supports Re-staging of Early-stage Hepatocellular Carcinoma · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05562830Phase 1/Phase 2 · recruiting A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A) · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05712356Phase 2 · completed A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05956093NA · active not recruiting 68Ga-FAPI PET/CT in the Staging of High-Grade Epithelial Ovarian Cancers: A Pilot Study · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06031805active not recruiting PRostate Olaparib Real World Evidence Study · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06331299Phase 3 · active not recruiting A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06388967recruiting Pancreatic Cancer Detection Consortium · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06726161Phase 1/Phase 2 · recruiting Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07144280Phase 3 · recruiting A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC) · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227012Phase 1/Phase 2 · recruiting Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body. · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07305428NA · recruiting Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07421700Phase 1/Phase 2 · recruiting Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594106Phase 1/Phase 2 · recruiting REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621718Phase 3 · recruiting Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691762Phase 3 · not yet recruiting A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844057Phase 2 · not yet recruiting First-line Treatment in Locally Advanced or Metastastic Small Bowel Adenocarcinoma · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Small Intestinal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07845266Phase 1 · completed Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GKL-006 Injection in Combination With TACE in Unresectable Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02123758Phase 1 · active not recruiting A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02498613Phase 2 · active not recruiting A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595931Phase 1 · active not recruiting M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03093922Phase 2 · completed A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03460977Phase 1 · recruiting A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03568656Phase 1/Phase 2 · completed Study to Evaluate CCS1477 in Advanced Tumours · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04071236Phase 1/Phase 2 · suspended Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04123379Phase 2 · active not recruiting Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC) · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216732recruiting Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858334Phase 2 · recruiting APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981119recruiting Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136196Phase 2 · recruiting BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05922930Phase 1/Phase 2 · active not recruiting Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084234Phase 4 · recruiting National Liver Cancer Screening Trial · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06136650Phase 3 · recruiting A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218914Phase 1 · recruiting Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06369610Phase 2 · active not recruiting Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06618664Phase 3 · recruiting A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma (KYLIN-02) · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06629779Phase 3 · recruiting A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06737913Phase 2 · recruiting HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06758401Phase 3 · recruiting This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1. · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06801236Phase 1 · recruiting Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06910670NA · active not recruiting Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07142005recruiting Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222566Phase 3 · recruiting Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07259317Phase 2 · recruiting Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07271355Phase 3 · recruiting Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07458906NA · recruiting DLL3-Targeted PET/CT in Neuroendocrine Carcinoma · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07489066Phase 2 · recruiting Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562152Phase 3 · recruiting Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07670312Phase 1/Phase 2 · recruiting Evaluation of XYA02 in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07673341Phase 2 · recruiting [18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07840456Phase 2 · not yet recruiting Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07842965Phase 1 · not yet recruiting CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293954NA · active not recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145141completed National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05237934recruiting Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC) · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05405673active not recruiting Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) for Colorectal Advanced Neoplasia · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Colorectal Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05863195Phase 3 · recruiting Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06052306Phase 1 · active not recruiting A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06447662Phase 1 · active not recruiting A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06693336Phase 2 · recruiting An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06836726Phase 2 · not yet recruiting Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06882746Phase 1 · terminated A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217496Phase 1 · not yet recruiting N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07719361Phase 1 · recruiting A Study in Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838415recruiting Multimodalomics-based Construction of Spatiotemporal Characteristics of Dynamic Liver Cancer Microenvironment to Characterize the Clinical Application of Immune Mechanisms in Liver Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07839767recruiting Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer Recurrence · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07840092recruiting Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05290194Phase 2 · withdrawn Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05489211Phase 2 · recruiting Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06302621Phase 1 · recruiting Pemigatinib + Afatinib in Advanced Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06491862recruiting RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06627647Phase 3 · recruiting A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915753Phase 1 · recruiting Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07025369Phase 2 · recruiting Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07291076Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07344220Phase 2 · enrolling by invitation Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835737Phase 1/Phase 2 · not yet recruiting Safety and Efficacy of Folic Acid Combined With Atezolizumab and Bevacizumab as First-Line Therapy for Unresectable Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836309not yet recruiting TACE in Combination With Tislelizumab and Lenvatinib for Advanced HCC (CHANCE2602) · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836530Phase 3 · not yet recruiting Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Relapsed Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836712Phase 2 · not yet recruiting Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836777Phase 2 · not yet recruiting Efficacy and Safety of MitoQ in Improving Cancer Cachexia · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07837622Phase 2 · not yet recruiting A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01660984active not recruiting Natural History Study of Children and Adults With Medullary Thyroid Cancer · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02314169Phase 2 · active not recruiting Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Anal Canal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03965689Phase 2 · active not recruiting Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04079712Phase 2 · active not recruiting Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04522570NA · completed Thermal Ablation of Cervical Metastases From Thyroid Carcinoma · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04671667Phase 2 · recruiting Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04963153Phase 1 · active not recruiting Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276973Phase 1 · active not recruiting Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05653960not yet recruiting Clinical Outcomes After EMR or ESD of Colorectal Neoplasms - A Multicenter Registry · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Colorectal Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06066138Phase 1 · recruiting A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06109272Phase 2/Phase 3 · active not recruiting A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC) · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06151574Phase 3 · active not recruiting Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06445062Phase 1/Phase 2 · recruiting Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06858813Phase 1 · recruiting A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC) · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06894511Phase 2 · active not recruiting An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07006727Phase 1 · recruiting Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Thymus Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07146646Phase 2 · recruiting Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213674Phase 3 · recruiting A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213791Phase 1 · recruiting A Study of LY4337713 in Participants With FAP-Positive Solid Tumors · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218380Phase 3 · recruiting A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07409272Phase 3 · recruiting A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07488676Phase 1/Phase 2 · recruiting A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570979Phase 1 · recruiting A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07596134NA · not yet recruiting Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07728019Phase 2 · recruiting Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823322Phase 2 · not yet recruiting A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824349Phase 1 · recruiting JUR-003 in Adult Patients With Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833839Phase 3 · not yet recruiting ZG005 Plus Etoposide and Cisplatin vs. Etoposide and Cisplatin as First-Line Treatment for Advanced Neuroendocrine Carcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835035Phase 1 · recruiting Rimegepant Plus Toripalimab in Advanced Urothelial Carcinoma After Failure of Standard Therapy · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02620852NA · recruiting Women Informed to Screen Depending on Measures of Risk (Wisdom Study) · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Breast Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02968732NA · active not recruiting Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03635892Phase 2 · active not recruiting A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Unclassified Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04104893Phase 2 · active not recruiting A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04543071Phase 2 · active not recruiting Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04615845Phase 1 · terminated A Phase 1 Study of Autologous Dendritic Cell Immunotherapy in Patients With mCRPC · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172258Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05521412Phase 1/Phase 2 · recruiting EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05878288Phase 2 · active not recruiting Deep sequencIng in Cutaneous Squamous CEll caRciNomas · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05904080Phase 2 · suspended Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05920798Phase 1/Phase 2 · active not recruiting Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983432Phase 1 · recruiting Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06005740Phase 1 · active not recruiting A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06040099Phase 2 · active not recruiting A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06439836Phase 1 · recruiting Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06929845NA · recruiting Organoid Models of Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07639138Phase 2 · recruiting Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793695Phase 2 · recruiting Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829926Phase 2 · not yet recruiting Lenvatinib Plus Tislelizumab With or Without Gefitinib for Advanced Liver Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831330Phase 2 · not yet recruiting Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832006Phase 2 · recruiting Irreversible Electroporation Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832227Phase 2 · not yet recruiting Imlunestrant/Abemaciclib/Selinexor in Ovarian and Endometrial · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Ovarian Low Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03391869Phase 3 · active not recruiting Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04047693Phase 2 · terminated Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma · condition mapped PROBABILISTIC · 8,639 trials mapped (2,922 active) | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04053842Phase 2 · completed Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291755enrolling by invitation Development and Analysis of a Stool Bank for Cancer Patients · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985565NA · active not recruiting Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05017025Phase 1/Phase 2 · completed Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05355363NA · completed Risk of Metachronous Findings After Detection of Serrated Lesions and High-grade Dysplasia With Surveillance Delay · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Colon Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06954116Phase 2 · recruiting Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07147361active not recruiting Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Cervical Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07365995Phase 3 · recruiting A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07627191early Phase 1 · recruiting GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07650240Phase 2 · recruiting Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07827807Phase 2 · not yet recruiting PEARL Trial: Partial TACE Enhancing Anti-tumor Response With Lenvatinib in Unresectable HCC · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07828236Phase 1 · not yet recruiting PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA · condition mapped CURATED_BROADER · 8,639 trials mapped (2,922 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02851784Phase 2/Phase 3 · recruiting Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04105270Phase 2 · recruiting RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial · condition mapped ALIAS · 8,639 trials mapped (2,922 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04152499Phase 1/Phase 2 · active not recruiting Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) · condition mapped ONTOLOGY_EXACT · 8,639 trials mapped (2,922 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |